Hua LIU (Watson)
Founding Partner & Chairman
Mr. Liu is a Chinese businessman and investor. He is the founder and executive of a Chinese stock market listed company JingFeng Pharmaceutical (SZ000908), CEO of GuiJing Capital. He is also a professional in IPO, Back door listing, M&A and familiar with the bond market. He was in charge of the JingFeng Pharmaceutical back door listing process.
Mr. Liu promoted the reform of JingFeng, and is the strategic designer of business improvement plan. He has rich experience in Business Incentive Mechanism, organizational structure, operation management, marketing and innovation, R&D, quality control, project management, corporate culture development.
Mr. Liu wields his influence in pharmaceutical industry investment and has strong connections with healthcare funds. He has successfully managed health care projects in gene sequencing, advanced medical device, innovative new drugs, high-end hospital and API.
He received Bachelor of Medicine from GuiYang Chinese Medicine College and hold EMBA degree from Cheung Kong Graduate School of Business.